Diligence memo · auto-generated · as of July 2, 2026

SL Seattle IMRT, LLC

SL Seattle IMRT, LLC looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

SL Seattle IMRT, LLC operates in Hospitals and Physicians, based in Bellaire.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

SL Seattle IMRT, LLC has raised $1.3M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $850K on 2010-07-07.

Most recent recorded round closed around 2010-07-07.

Valuation (modeled)modeled

Provath models SL Seattle IMRT, LLC at approximately $24M (range $555K–$276M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.90× the median modeled value of Pre-Seed Hospitals and Physicians companies in 2010–2012 (46 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 486 months.

Last raise 16.0 yr ago; this sector typically re-raises about every 12 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 1.8× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 43% of Hospitals and Physicians peers (599 compared).

Modeled value ranks above 51% of those peers.

Closest niche peers: SL Denver Leasing, LLC, Livingston Hemodialysis Partners, LLC, Greater Norman Surgery Center LLC, Victory Landmark Real Estate, LLC, Malo Clinic Center for Ambulatory Surgery, LLC.

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.